Rapid Micro Biosystems (RPID) Free Cash Flow (2020 - 2026)

Rapid Micro Biosystems has disclosed Free Cash Flow across 7 years of filings, most recently posting -$15.5 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$15.5 million, down 64.66% year-over-year; the trailing twelve-month figure through Mar 2026 was -$38.0 million (up 2.09% YoY), and the FY2025 annual result was -$31.9 million, up 29.89% from the prior year.
• Free Cash Flow came in at -$15.5 million for Q1 2026 at Rapid Micro Biosystems, down from -$4.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of -$4.0 million in Q4 2025 to a low of -$20.7 million in Q3 2022.
• The 5-year median for Free Cash Flow is -$10.0 million (2023), against an average of -$11.6 million.
• Across the five-year window, Free Cash Flow jumped 64.15% in 2025 and slumped 64.66% in 2026, its largest moves.
• Rapid Micro Biosystems' Free Cash Flow stood at -$6.3 million in 2022, then slumped by 54.86% to -$9.7 million in 2023, then fell by 15.51% to -$11.2 million in 2024, then surged by 64.15% to -$4.0 million in 2025, then tumbled by 283.23% to -$15.5 million in 2026.
• The last three Free Cash Flow figures came in at -$15.5 million (Q1 2026), -$4.0 million (Q4 2025), and -$9.0 million (Q3 2025), per Business Quant data.